-
Dabrafenib
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Dabrafenib -
Aprocitentan
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Aprocitentan -
Tirzepatide
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Tirzepatide Type 2 shuga mellitus, kuchepetsa thupi Eli Lilly Jan.05,2036 -
Semaglutide
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Semaglutide Type2 shuga mellitus, kuchepetsa thupi Novo Nordisk Dec.05,2031 -
Oteseconazole
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Oteseconazole Chepetsani kuchuluka kwa zochitika kawirikawiri vulvovaginal candidiasis
Malingaliro a kampani MycoviaPharmaceuticals Apr.22,2031 -
Finerenone
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Finerenone Matenda a shuga a nephropathy Bayer Apr.12,2029 -
Capivasertib
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Capivasertib khansa ya m'mawere AstraZeneca Mar. 10.2030 -
Resmetirom
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Resmetirom NASH Roche Sep.12,2026 -
Darolutamide
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Darolutamide chithandizo cha khansa ya prostatic Bayer Marichi 25,2033 -
Upadacitinib
Dzina la API Chizindikiro Woyambitsa Tsiku Lomaliza Ntchito (The US) Upadacitinib Dermatitis ya Atopic Malingaliro a kampani ABBVIE INC Dec.01,2030
